Ontology highlight
ABSTRACT: Background
Despite successes in the development of innovative anticancer therapies, the fiscal and capacity restraints of the Canadian public healthcare system result in challenges with drug access. A meaningful proportion of systemic therapies ultimately do not receive public funding despite supporting clinical evidence. In this study, we assessed Canadian medical oncologists' current attitudes toward discussing publicly unfunded cancer treatments with patients and predictors of different practices.Methods
A web-based survey consisting of multiple choice and case-based scenarios was distributed to medical oncologists identified through the Royal College of Physicians and Surgeons of Canada directory.Results
A total of 116 responses were received. Almost all respond
SUBMITTER: Wong SK
PROVIDER: S-EPMC8628663 | biostudies-literature | 2021 Nov
REPOSITORIES: biostudies-literature